Return to Listing

5 result(s) for Sarcoma

PI Name Protocol # Title
Christopher Ryan IRB00009464 A Phase II Study of Sorafenib with Chemotherapy, Radiation, and Surgery for High-Risk Soft Tissue Sarcomas
Lara Davis IRB00012039 Sarcoma Survivorship Registry
Lara Davis STUDY00016039 [NCI CIRB] A Phase 2 Study of GPNMB-targeted Antibody-Drug Conjugate, CDX-011 (Glembatumumab Vedotin, CR011-vcMMAE; IND# 128248, NSC# 763737), in Recurrent or Refractory Osteosarcoma
Lara Davis STUDY00016146 Randomized Phase IIb Trial of Vigil™ (bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) versus gemcitabine + docetaxel for Ewing’s Sarcoma
Arthur Hung STUDY00016373 A Pilot Study Investigating 18F-FLT-PET as a Marker of Response to Preoperative Radiotherapy in Soft Tissue Sarcoma

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080